Effect of ubiquinon on Gastric cancer

Evaluation the efficacy of Ubiquinon on Tumor markers in patients with Gastric cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016120826390N8

Enrollment

Registered

2016-12-13

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer. Malignant neoplasm of stomach

Interventions

Intervention 1: Patients will experience CoenzymeQ10 200 mg supplementation under supervision of dietition for 3 month intervention group. Intervention 2: Patients in control group will take placebo i

Treatment - Drugs

Placebo

Patients will experience CoenzymeQ10 200 mg supplementation under supervision of dietition for 3 month intervention group

Patients in control group will take placebo in the same number as intervention group for 3 month.

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 25 to 75 years old; healthy function of liver and kidney; gastric cancer diagnosis. Exclusion criteria: chemotherapy; food supplement or other dietary regimen; diabetes mellitus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Carcinoembryonic Antigen. Timepoint: Before and after study. Method of measurement: Laboratory kits.;Carbohydraate Antigen 19-9. Timepoint: Before and after study. Method of measurement: Laboratory kits.;Carbohydraate Antigen 125. Timepoint: Before and after study. Method of measurement: Laboratory kits.	—

Secondary

Measure	Time frame
Weight. Timepoint: Befor and after Study. Method of measurement: Sensitive Balance.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Ahmadzadeh

Ahwaz Jundishapoor University of Medical Science

crc@ajums.ac.ir+98 61 3374 3285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026